Form 4: IBM Director Laguarta Defers Fees into 126 Shares

Sentiment:

Insider Transaction Report


IBM Director Ramon Laguarta defers compensation into 126 Promised Fee Shares under the company's deferred compensation plan.

Summary

  • Ramon Laguarta, a Director at International Business Machines Corp (IBM), deferred fees into 126 Promised Fee Shares.
  • This transaction occurred on March 31, 2026, under the IBM Board of Directors Deferred Compensation and Equity Award Plan.
  • The price of the derivative security (Promised Fee Share) was $242.39.
  • These shares are structured to be paid out after retirement in IBM common stock or cash, with distribution deferred until retirement.
  • Following this transaction, Laguarta beneficially owns 126 Promised Fee Shares directly.
  • A Power of Attorney dated March 1, 2026, authorizes several IBM employees to sign and file SEC forms on Laguarta's behalf.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as a director's decision to defer compensation into company shares indicates confidence in IBM's future prospects and aligns their interests with long-term shareholder value.

Positives

  • Director Ramon Laguarta's decision to defer fees into company shares demonstrates continued confidence in IBM's long-term performance.
  • The deferred compensation plan aligns director incentives with long-term shareholder value.

Future Outlook

The Promised Fee Shares are structured to be paid out after retirement, indicating a long-term commitment to the company's stock.

Industry Context

StockSavvy.ai notes that deferred compensation plans, particularly those involving equity, are a common practice in corporate governance for aligning the interests of directors and executives with long-term shareholder value. This type of transaction is standard for director compensation at large public companies.

Comparison to Industry Standards

  • Many S&P 500 companies, including peers like Microsoft and Apple, offer similar deferred compensation plans for their non-employee directors, allowing them to elect to receive all or a portion of their annual retainer in company stock or deferred units.
  • The structure of deferring fees into equity until retirement is a widely adopted best practice to foster long-term commitment and reduce short-term trading incentives among board members.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Power of Attorney AuthorizationRamon Laguarta authorized several IBM employees to sign and file SEC forms on his behalf, including Form 3, Form 4, Form 5, and Form 144.03/01/2026Streamlines the process for filing required insider trading reports for the director, ensuring timely compliance with SEC regulations.

Stakeholder Impact

  • Shareholders: The deferral of director fees into equity aligns the director's financial interests with long-term shareholder value, potentially fostering more shareholder-centric decision-making.

Next Steps

  • Distribution of the 126 Promised Fee Shares will occur after Ramon Laguarta's retirement from IBM.

Key Dates

DateDescription
03/01/2026Date of Power of Attorney authorization.
03/31/2026Date of earliest transaction for deferral of fees into Promised Fee Shares.
04/01/2026Date of signature for the Form 4 filing.

Recommendation

hold

This Form 4 filing details a routine director compensation deferral into company shares, which is a positive signal of insider confidence but does not present new material information significant enough to alter an investment thesis. It reinforces a 'hold' recommendation for investors already positioned in IBM, as it indicates stable corporate governance and director alignment without suggesting immediate catalysts for significant price movement.

Keywords

IBM, Ramon Laguarta, Form 4, Director Compensation, Deferred Compensation, Equity Award Plan, Promised Fee Shares, Insider Transaction

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.